Do Diagnostic Nerve Blocks Affect the Starting Dose of Botulinum Neurotoxin Type A for Spasticity? A Case-Control Study
Mirko Filippetti(University of Verona), Alessandro Picelli(University of Verona), Andrea Santamato(University of Foggia), Marco Battaglia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Rita Di Censo(University of Verona), Roberto Aldegheri(University of Verona), Stefano Tamburin(University of Verona), Alessio Baricich(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Elisa Mantovani(University of Verona), Stefania Spina(University of Foggia), Nicola Smania(University of Verona)
Cited by 5
Related Papers
Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation
|Parkinson s Disease|2016|374
Virtual Reality Telerehabilitation for Postural Instability in Parkinson’s Disease: A Multicenter, Single-Blind, Randomized, Controlled Trial
|BioMed Research International|2017|325
Rehabilitation procedures in the management of spasticity.
|PubMed|2010|168
Platinum‐induced peripheral neurotoxicity: From pathogenesis to treatment
|Journal of the Peripheral Nervous System|2019|149